Trade Bristol Myers ^BMY

Is Bristol Myers Squibb (BMY) Pricing Reflect Long Term Cash Flow Prospects At US$55.92?

Leerink Partners Issues Positive Forecast for Bristol Myers Squibb (NYSE:BMY) Stock Price

Acute Myeloid Leukemia Market Analysis and Forecast, 2025-2035: Precision Medicine Leads Growth

10 Cheap S&P 500 Stocks to Invest in Now

Oramed and Lifeward Announce Strategic Transaction PR Newswi

Bristol Myers Squibb Company $BMY Shares Sold by GRIMES & Co WEALTH MANAGEMENT LLC

Cheaper Cancer Drugs vs Patents: Will Delhi HC's Zydus Ruling Expand Access To Treatment? | Explainers News - News18

Bristol Myers Squibb Company $BMY Position Raised by Sumitomo Mitsui Trust Group Inc. - Daily Political

Linavonkibart and pembrolizumab in immune checkpoint blockade-resistant advanced solid tumors: a phase 1 trial

Scotiabank Raises Bristol-Myers (BMY) PT to $60 Citing Catalyst-Rich 2026 Growth

SAN FRANCISCO-Bristol Myers…

Critical Review: Bristol Myers Squibb (NYSE:BMY) & VivoSim Labs (NASDAQ:VIVS) - Markets Daily

First Horizon Corp Acquires New Holdings in Bristol Myers Squibb Company $BMY

Head to Head Comparison: VivoSim Labs (NASDAQ:VIVS) & Bristol Myers Squibb (NYSE:BMY) - Stock Observer

Tema Etfs LLC Purchases 25,997 Shares of Bristol Myers Squibb Company $BMY - Daily Political

Modulation of the clonal burden in patients with lower-risk myelodysplastic neoplasms treated with imetelstat

Here are the 3 big things we're watching in the stock market in the week ahead

Bristol Myers Squibb Company $BMY Shares Bought by New York State Teachers Retirement System - Daily Political

Nepsis Inc. Decreases Stake in Bristol Myers Squibb Company $BMY

Nisa Investment Advisors LLC Purchases 83,401 Shares of Bristol Myers Squibb Company $BMY

MADDEN SECURITIES Corp Sells 23,426 Shares of Bristol Myers Squibb Company $BMY - Stock Observer

Oregon Public Employees Retirement Fund Buys 56,749 Shares of Bristol Myers Squibb Company $BMY - Daily Political

Did UBS's Pipeline-Driven Upgrade Just Shift Bristol-Myers Squibb's (BMY) Investment Narrative?

Next Level Private LLC Has $2.54 Million Position in Bristol Myers Squibb Company $BMY

The Motley Fool: What's 'the Dow'? - UPSTATE BUSINESS JOURNAL

SG Americas Securities LLC Has $75.53 Million Stake in Bristol Myers Squibb Company $BMY

SG Americas Securities LLC Buys 1,177,732 Shares of Bristol Myers Squibb Company $BMY - Stock Observer

Is Bristol Myers Squibb (BMY) Quietly Recasting Its Post-Patent Story With Opdivo And KarXT Moves?

Clinical outcomes with perioperative nivolumab by nodal status in patients with stage III resectable NSCLC: phase 3 CheckMate 77T exploratory analysis

Assessing Bristol Myers Squibb (BMY) Valuation As Shares Gain And Profitability Narrative Evolves

Is Bristol Myers Squibb (BMY) Pricing Reflect Recent Opdivo And Eliquis Patent Cliff Risks

How Bristol Myers Squibb Transformed Working Capital to Fund Its Future - SPONSOR CONTENT FROM EY-PARTHENON

UBS Group Upgrades Bristol Myers Squibb (NYSE:BMY) to Buy

Bristol Myers Squibb (NYSE:BMY) Rating Increased to Buy at UBS Group - Markets Daily

Integras Partners LLC Buys 22,141 Shares of Bristol Myers Squibb Company $BMY

Bristol Myers Squibb Company $BMY Shares Sold by Commonwealth Equity Services LLC

Oncology Biosimilars: Biocon to Launch Keytruda Biosimilars at JPM 2026 Conference, ETPharma

Assessing Bristol Myers Squibb (BMY) Valuation After New Eliquis Pact Trial Update And Opdivo Approval

Alnuctamab, a bivalent B-cell maturation antigen-targeting T cell engager for patients with relapsed or refractory multiple myeloma: results from a phase 1, first-in-human study

CD19 CAR-T cells for treatment-refractory autoimmune diseases: the phase 1/2 CASTLE basket trial

Gladstone Institutional Advisory LLC Has $4.50 Million Stock Holdings in Bristol Myers Squibb Company $BMY - Markets Daily

Bristol Myers Squibb Company $BMY Position Decreased by D.A. Davidson & CO.

Robeco Institutional Asset Management B.V. Buys 409,231 Shares of Bristol Myers Squibb Company $BMY - Stock Observer

Is Bristol Myers Squibb (BMY) Pricing Reflect Pipeline Progress And DCF Valuation Gap

Railway Pension Investments Ltd Purchases 40,300 Shares of Bristol Myers Squibb Company $BMY

Bristol Myers Squibb Company $BMY Shares Acquired by CWA Asset Management Group LLC

The Motley Fool: Dividends and a chance for growth

Binimetinib and encorafenib for the treatment of advanced solid tumors with non-V600E BRAF mutations: results from the Phase II BEAVER trial

Bristol Myers Squibb to Present at J.P. Morgan's 44th Annual Healthcare Conference

Allspring Global Investments Holdings LLC Acquires 434,745 Shares of Bristol Myers Squibb Company $BMY

Tumor ecosystem and microbiome features associated with efficacy and resistance to avelumab plus chemoradiotherapy in head and neck cancer

Bristol Myers Squibb Sees Unusually Large Options Volume (NYSE:BMY) - Markets Daily

Drugmakers hike US prices on 350 medicines despite pressure from Trump

Bristol Myers Squibb Sees Unusually High Options Volume (NYSE:BMY) - Stock Observer

VIRGINIA RETIREMENT SYSTEMS ET Al Grows Stock Holdings in Bristol Myers Squibb Company $BMY

3Chopt Investment Partners LLC Sells 36,326 Shares of Bristol Myers Squibb Company $BMY

VIRGINIA RETIREMENT SYSTEMS ET Al Acquires 679,000 Shares of Bristol Myers Squibb Company $BMY - Daily Political

Goldman Sachs Raises Bristol-Myers (BMY) Target, Keeps Neutral Rating

Bristol Myers Squibb Company $BMY Shares Purchased by Fort Washington Investment Advisors Inc. OH

Bristol Myers Squibb Company $BMY Shares Sold by Range Financial Group LLC

Ethic Inc. Raises Stock Holdings in Bristol Myers Squibb Company $BMY

What Does Wall Street Think About Bristol-Myers Squibb Company (BMY)?

Biotech Stocks Facing FDA Decision In January 2026

Bristol Myers Squibb Company $BMY Stock Holdings Reduced by Valley National Advisers Inc.

Spotlight | - The Times of India

An ultrasmall core-shell silica nanoparticle improves antitumour immunity and survival by remodelling suppressive melanoma microenvironments

Bristol Myers Squibb Company $BMY Shares Bought by Cwm LLC

Efficacy and safety of isatuximab subcutaneous plus carfilzomib and dexamethasone in patients with relapsed/refractory multiple myeloma: results of the Phase 2 study IZALCO

Donald L. Hagan LLC Purchases Shares of 20,550 Bristol Myers Squibb Company $BMY

Bristol Myers Squibb Company $BMY Shares Sold by Pacer Advisors Inc. - Stock Observer

Trust Co. of Toledo NA OH Increases Stock Position in Bristol Myers Squibb Company $BMY - Daily Political

Medical Stocks Worth Watching - December 25th - Daily Political

Bristol Myers Squibb (BMY): Reassessing Valuation After Breyanzi's Landmark FDA Approval in Marginal Zone Lymphoma

Vontobel Holding Ltd. Sells 46,675 Shares of Bristol Myers Squibb Company $BMY - Markets Daily

Vontobel Holding Ltd. Lowers Stock Position in Bristol Myers Squibb Company $BMY - Stock Observer

Bristol Myers Squibb Company (NYSE:BMY) Given Consensus Recommendation of "Hold" by Brokerages

Is Bristol Myers Squibb (BMY) Still Undervalued After Its Recent Share Price Rebound?

Bristol Myers Squibb Accelerates Drug Launches in India with AI Innovations, ETPharma

Bristol-Myers (BMY) Offers Eliquis Free to Medicaid Patients Under New Pricing Pact

Bristol Myers lines up many launches for India with 'AI' speed - The Economic Times

Four quiet Q4 winners and what the stocks must do to keep rolling in 2026

U.S. Capital Wealth Advisors LLC Sells 47,717 Shares of Bristol Myers Squibb Company $BMY

Coho Partners Ltd. Has $2.18 Million Stock Holdings in Bristol Myers Squibb Company $BMY

True North Advisors LLC Takes Position in Bristol Myers Squibb Company $BMY - Stock Observer

Trust Co. of Vermont Has $2.55 Million Stock Holdings in Bristol Myers Squibb Company $BMY - Stock Observer

Exchange Traded Concepts LLC Purchases 83,214 Shares of Bristol Myers Squibb Company $BMY

Bristol Myers Squibb Company $BMY Shares Sold by First Bank & Trust

Vagus nerve-mediated neuroimmune modulation for rheumatoid arthritis: a pivotal randomized controlled trial

FDA Approves Bristol-Myers Squibb's Breyanzi as First-Ever CAR T Therapy for Rare Marginal Zone Lymphoma

BofA Upgrades Bristol-Myers Squibb (BMY) Stock to Buy from Neutral

Bristol Myers Squibb Company $BMY Shares Sold by Wedge Capital Management L L P NC